KP Tissue Reports Revenue Growth and Declares Quarterly Dividend

KP Tissue and its 12%-owned Kruger Products reported stronger third-quarter 2026 results: revenue rose 5.1% year over year to $589.7 million, adjusted EBITDA increased 9.1% to $93.5 million, and net income grew to $27.7 million from $14.6 million. Management cited sales growth in the U.S. and Canada, while warning of higher input costs and inflation; it is considering productivity measures and pricing changes, and has delayed choosing a location for a new facility pending greater economic and trade certainty. KP Tissue also declared a quarterly dividend of $0.21 per share, payable January 15, 2027, to shareholders of record December 31. The dividend is designated non-eligible for Canadian tax purposes, and the companies said they are working toward restoring eligible-dividend treatment.